Literature DB >> 25637601

Dual regulation of δ-opioid receptor function by arachidonic acid metabolites in rat peripheral sensory neurons.

Laura C Sullivan1, Kelly A Berg1, William P Clarke2.   

Abstract

The regulation of opioid receptor system function in peripheral sensory neurons is not well understood. Opioid agonist efficacy to inhibit nociceptor function and to promote antinociception is generally weak under basal conditions and frequently no response occurs. However, in response to a cyclooxygenase-dependent metabolite of arachidonic acid (AA) after exposure to inflammatory mediators, such as bradykinin (BK) or exogenous AA, peripheral opioid receptor systems become much more responsive to opioid agonists. In this study, we examined the time course for the induction and maintenance of functional competence of the δ-opioid receptor (DOR) system in adult rat nociceptors in culture and in vivo. We found that the responsive state of DOR after pretreatment with BK or exogenous AA is transient (30-60 minutes) and persists for 15-30 minutes after a 15-minute exposure of nociceptors to BK or AA. Interestingly, whereas functional competence of the DOR system could be reinduced with a second application of BK 60 minutes after the first, responsiveness of the DOR system could not be reinduced after an initial exposure to AA. This nonresponsive state of DOR after exogenous AA was mediated by a lipoxygenase (LOX)-dependent metabolite of AA. Intraplantar carrageenan also produced transient DOR functional competence and responsiveness was also reinduced by inhibition of LOX. Thus, the DOR system expressed by peripheral sensory neurons is under dual regulation by cyclooxygenase- and LOX-dependent metabolites of AA.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25637601      PMCID: PMC4366754          DOI: 10.1124/jpet.114.221366

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  35 in total

1.  Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation.

Authors:  R A Dionne; A M Lepinski; S M Gordon; L Jaber; J S Brahim; K M Hargreaves
Journal:  Clin Pharmacol Ther       Date:  2001-07       Impact factor: 6.875

2.  Signaling cascades for δ-opioid receptor-mediated inhibition of GABA synaptic transmission and behavioral antinociception.

Authors:  Zhi Zhang; Zhizhong Z Pan
Journal:  Mol Pharmacol       Date:  2011-12-05       Impact factor: 4.436

3.  Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons.

Authors:  Kelly A Berg; Matthew P Rowan; Achla Gupta; Teresa A Sanchez; Michelle Silva; Ivone Gomes; Blaine A McGuire; Philip S Portoghese; Kenneth M Hargreaves; Lakshmi A Devi; William P Clarke
Journal:  Mol Pharmacol       Date:  2011-11-09       Impact factor: 4.436

4.  Analgesic effects of intra-articular morphine in patients with temporomandibular joint disorders: a prospective, double-blind, placebo-controlled clinical trial.

Authors:  Christoph M Ziegler; Jan Wiechnik; Joachim Mühling
Journal:  J Oral Maxillofac Surg       Date:  2010-03       Impact factor: 1.895

Review 5.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 6.  Opioids and sensory nerves.

Authors:  Christoph Stein; Christian Zöllner
Journal:  Handb Exp Pharmacol       Date:  2009

7.  Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.

Authors:  Kelly A Berg; Matthew P Rowan; Teresa A Sanchez; Michelle Silva; Amol M Patwardhan; Stephen B Milam; Kenneth M Hargreaves; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2011-04-12       Impact factor: 4.030

Review 8.  Opioids: a two-faced Janus.

Authors:  Karsten Ahlbeck
Journal:  Curr Med Res Opin       Date:  2011-01-03       Impact factor: 2.580

9.  Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain.

Authors:  Ilona Obara; Jan Rodriguez Parkitna; Michal Korostynski; Wioletta Makuch; Dorota Kaminska; Barbara Przewlocka; Ryszard Przewlocki
Journal:  Pain       Date:  2009-01-14       Impact factor: 6.961

Review 10.  Peripheral mechanisms of opioid analgesia.

Authors:  Christoph Stein; Leonie Julia Lang
Journal:  Curr Opin Pharmacol       Date:  2009-01-20       Impact factor: 5.547

View more
  14 in total

1.  Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons.

Authors:  Blaine A Jacobs; Miryam M Pando; Elaine M Jennings; Raehannah J Jamshidi; Joshua C Zamora; Teresa S Chavera; William P Clarke; Kelly A Berg
Journal:  Neuropharmacology       Date:  2019-02-15       Impact factor: 5.250

2.  Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.

Authors:  Raehannah J Jamshidi; Blaine A Jacobs; Laura C Sullivan; Teresa A Chavera; Rachel M Saylor; Thomas E Prisinzano; William P Clarke; Kelly A Berg
Journal:  J Pharmacol Exp Ther       Date:  2015-08-21       Impact factor: 4.030

Review 3.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

4.  Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.

Authors:  Raehannah J Jamshidi; Laura C Sullivan; Blaine A Jacobs; Teresa A Chavera; Kelly A Berg; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2016-09-07       Impact factor: 4.030

5.  Allosterism within δ Opioid-κ Opioid Receptor Heteromers in Peripheral Sensory Neurons: Regulation of κ Opioid Agonist Efficacy.

Authors:  Blaine A Jacobs; Miryam M Pando; Elaine Jennings; Teresa A Chavera; William P Clarke; Kelly A Berg
Journal:  Mol Pharmacol       Date:  2018-02-07       Impact factor: 4.436

6.  Regulation of δ Opioid Receptor-Mediated Signaling and Antinociception in Peripheral Sensory Neurons by Arachidonic Acid-Dependent 12/15-Lipoxygenase Metabolites.

Authors:  Laura C Sullivan; Teresa A Chavera; Xiaoli Gao; Miryam M Pando; Kelly A Berg
Journal:  J Pharmacol Exp Ther       Date:  2017-05-02       Impact factor: 4.030

7.  Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.

Authors:  Laura C Sullivan; Teresa S Chavera; Raehannah J Jamshidi; Kelly A Berg; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2016-09-22       Impact factor: 4.030

8.  GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity.

Authors:  Allison Doyle Brackley; Ruben Gomez; Armen N Akopian; Michael A Henry; Nathaniel A Jeske
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

9.  Delta opioid receptor regulation of calcitonin gene-related peptide dynamics in the trigeminal complex.

Authors:  Laura S Moye; Kendra Siegersma; Isaac Dripps; Wiktor Witkowski; Elizaveta Mangutov; Dong Wang; Grégory Scherrer; Amynah A Pradhan
Journal:  Pain       Date:  2021-08-01       Impact factor: 7.926

10.  GRK2 Dictates a Functional Switch of the Peripheral Mu-Opioid Receptor.

Authors:  Yan Zhang; Nathaniel A Jeske
Journal:  ACS Chem Neurosci       Date:  2020-11-11       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.